Thomas J. Herzfeld Advisors, Inc. Zoetis Inc. Transaction History

Thomas J. Herzfeld Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$167.14 - $192.77 $5,515 - $6,361	33 New	33 $5.74 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $482 - $558	-3 Reduced 8.11%	34 $5,000
Q2 2021 Aug 16, 2021	BUY	$155.9 - $187.99 $1,870 - $2,255	12 Added 48.0%	37 $7,000
Q2 2020 Aug 12, 2020	SELL	$111.92 - $142.53 $4,476 - $5,701	-40 Reduced 61.54%	25 $4,000
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $3,022 - $3,464	-26 Reduced 28.57%	65 $9,000
Q2 2019 Aug 13, 2019	SELL	$97.98 - $114.28 $391 - $457	-4 Reduced 4.21%	91 $10,000
Q1 2019 May 14, 2019	BUY	$81.56 - $100.67 $815 - $1,006	10 Added 11.76%	95 $10,000
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $6,078 - $7,198	85 New	85 $7,000

1,921

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $84.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.